Product Images Doxazosin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Doxazosin NDC 0093-2070 by Teva Pharmaceuticals Usa, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

image 1

image 1

image 2

image 2

This appears to be a chart or table of various studies involving the drug doxazosin mesylate and its effects on patients with benign prostatic hyperplasia (BPH). The studies involved titration to different doses and measured the maximum flow rate and symptom score of patients compared to a placebo group. The table includes numerical values representing change from baseline and notes on the study design and measurement methods.*

image 3

image 3

This text appears to be a graph showing the mean change in symptoms and maximum urinary flow rate for patients with a certain condition during weeks of treatment. The graph includes a comparison of a doxazosin treatment to a placebo treatment, with statistical significance marked. No further information is available.*

image 4

image 4

This is a prescription medication containing doxazosin mesylate that comes in tablet form. Each tablet is equivalent to 1 mg of doxazosin as a free base. The recommended dosage is not mentioned, and it is advised to consult the prescribing information. It should be stored at a temperature of 20° to 25°C (68° to 77°F) in a well-closed container. The manufacturing company is Piramal Pharma Limited, and it is manufactured for Teva Pharmaceuticals USA, Inc. The rest of the text includes manufacturing and serialization information.*

image 5

image 5

This is a description of a medication called Doxazosin, which comes in a bottle of 100 tablets. Each tablet contains 2 mg of Doxazosin mesylate. The recommended dosage is specified in the prescribing information. The medication should be kept at 20-25°C (68-77°F) and dispensed in a well-closed container. It should be kept out of the reach of children. The medication is manufactured in India by Piramal Pharma Limited for Teva Pharmaceuticals USA, Inc., Parsippany, NJ. The NDC number for this medication is 0093-2069-01.*

image 6

image 6

This is a medication information for 0xazosin, which contains doxazosin mesylate equivalent to 4mg doxazosin as a free base per tablet. The appropriate dosage should be determined by the prescribing information. The medication should be stored in a well-closed container at a temperature between 20°C to 25°C. It is manufactured by Piramal Pharma Limited in India and distributed by Teva Pharmaceuticals in the USA. The provided NDC code is 0093-2068-01 and the medication is available in a bottle of 100 tablets.*

image 7

image 7

This is a description for a medication called doxazosin mesylate, which comes in tablet form. Each tablet contains 8 mg of doxazosin, as a free base. The medication is prescribed according to the instructions given, and it should be stored at a controlled room temperature. The drug is manufactured by Piramal Pharma Limited, located in Pithampur, Madhya Pradesh, India, under license number 25/10/92. These tablets are exclusively manufactured for Teva Pharmaceuticals USA, Inc. The text also includes some product information such as the NDC code, recommended dosage, and a warning to keep medications out of reach of children.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.